How many tablets of eltrombopag are recommended to be taken a day?

Eltrombopag (Eltrombopag) is an oral thrombopoietic agent, mainly used to treat chronic immune thrombocytopenia (ITP), liver disease-related thrombocytopenia, aplastic anemia and other diseases. It effectively improves a patient's platelet levels by stimulating megakaryocytes in the bone marrow to produce more platelets. Correct dosage and administration are crucial to ensure efficacy and reduce side effects.

Typically, the starting dose of eltrombopag varies based on the patient's specific condition. For adult patients with chronic immune thrombocytopenia, the recommended starting dose is generally 25 mg once daily (i.e. 25 mg per tablet). The specific number of tablets needs to be adjusted according to the drug specifications. Doctors will adjust the dose every 2 weeks according to the patient's platelet response, gradually increasing or decreasing it, in order to achieve the goal of effectively increasing the platelet count while avoiding excessive platelet count.

The dosage of eltrombopag may vary in patients with liver disease-associated thrombocytopenia, often with lower starting doses and slower titration, as these patients may have impaired liver function and are less able to metabolize the drug. For safety reasons, patients should strictly follow the doctor's instructions and take medication, and regularly monitor platelet count and liver function to avoid adverse reactions such as excessive platelet count or liver damage.

In general, the number of eltrombopag tablets taken a day should be strictly based on the doctor's prescription and the patient's specific condition. Patients should not increase or decrease the dose or stop medication at will, so as not to affect the therapeutic effect or cause serious complications. If abnormal symptoms occur while taking the medicine, you should seek medical treatment promptly and inform the doctor so that the treatment plan can be adjusted in a timely manner.

Reference materials:https://go.drugbank.com/drugs/DB06210